Sodium–glucose cotransporter-2 inhibitors and clinical outcomes in patients with hypertrophic cardiomyopathy and diabetes: a population-based cohort study - Poll - MDSpire

Sodium–glucose cotransporter-2 inhibitors and clinical outcomes in patients with hypertrophic cardiomyopathy and diabetes: a population-based cohort study

  • By

  • Mi-Hyang Jung

  • Jung Sun Cho

  • So-Young Lee

  • Jong-Chan Youn

  • Young Choi

  • Woo-Baek Chung

  • Jungkuk Lee

  • Dongwoo Kang

  • Woojin Kwon

  • Tae-Seok Kim

  • Sang-Hyun Ihm

  • Hae Ok Jung

  • November 22, 2024

  • 0 min

Share

Original Source(s)

Sodium–glucose cotransporter-2 inhibitors and clinical outcomes in patients with hypertrophic cardiomyopathy and diabetes: a population-based cohort study

  • by Mi-Hyang Jung, Jung Sun Cho, So-Young Lee, Jong-Chan Youn, Young Choi, Woo-Baek Chung, Jungkuk Lee, Dongwoo Kang, Woojin Kwon, Tae-Seok Kim, Sang-Hyun Ihm, Hae Ok Jung

  • November 22, 2024

Related Content

Prognostic value of CTI for major adverse cardiovascular events in patients With ST-elevation myocardial infarction after primary percutaneous coronary intervention

Transcatheter closure of PDA: how the pathway changed from classical fluoroscopy approach

Correction: Multicriteria Optimization of Language Models for Heart Failure With Preserved Ejection Fraction Symptom Detection in Spanish Electronic Health Records: Comparative Modeling Study